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Micronutrients in gastrointestinal cancer
S.N. Georgiannos, P.M.T. Weston & A.W. Goode
Surgical Unit, The Royal London Hospital Medical College, Whitechapel, London El JBB, UK.
Summary The monitoring of micronutrients and the relationship between dietary intake and micronutrient
status prior to and after surgery in patients with histologically proven gastrointestinal adenocarcinoma, both
weight-stable and weight-losing (>7.5% of their pre-illness weight) has been studied and the results compared
to controls.
Plasma vitamin C and red blood cell thiamine levels were significantly lower in weight-losing cancer patients
when compared to their weight-stable counterparts (P<0.05 and P<0.02 respectively). Weight-losing patients
had a lower vitamin C (P<0.05) and thiamine (P<0.002) intake, and a higher elevation in plasma C-reactive
protein and a lower prealbumin level (P<0.02), when compared to both weight-stable cancer patients and
controls.
Plasma vitamin C, prealbumin and C-reactive protein levels remained unchanged after curative resections of
the tumours compared to a preoperative value, and there was a highly significant correlation between plasma
vitamin C and dietary intake of vitamin C.
This study suggests that the lower vitamin C and thiamine status in weight-losing gastrointestinal cancer
patients prior to surgery is due to a lower micronutrient intake and an acute phase response to their illness.
Dietary intake of vitamin C appears to be the major factor in determining plasma vitamin C concentration
following curative surgical resection.
It has been suggested that vitamin C might have a role in
both the pathogenesis and therapy of malignant disease
(Husami & Abumrad, 1986), (McKeown-Eyssen et al., 1988).
In a number of studies, vitamin C has been estimated in
plasma and the buffy layer in mixed groups of cancer
patients. A review of such studies by Cameron et al. (1979)
has shown low values for vitamin C, particularly for buffy
coat vitamin C, in groups of heterogeneous cancer
patients.
Thiamine pyrophosphate, which is the active form of
thiamine in tissues, functions as an important cofactor for
the enzymes pyruvate dehydrogenase and alpha-ketoglutarate
dehydrogenase in the Krebs cycle. It also functions as a
cofactor for the enzyme transketolase in the phospho-
gluconate pathway, which is an important source of NADPH
and is a scavenger pathway for excessive ribose-5-phosphate
(Caldwell & Kennedy-Caldwell, 1984). Thiamine require-
ments are increased during stress, excessive carbohydrate
intake and chronic alcoholism (Husami & Abumrad, 1986).
Biochemical deficiency can be demonstrated within a few
weeks of cessation of thiamine intake. In addition, Singh has
demonstrated that thiamine deficiency induces a reduction in
body weight, pancreatic protein, and digestive enzyme con-
tent in Sprague-Dawley rats while increasing protein and
digestive enzyme secretion from the pancreas (Singh,
1982).
The aim of the present work was the monitoring of micro-
nutrients in gastrointestinal cancer and to investigate the
relationship between dietary intake and micronutrient status
prior to and after surgery.
clinical details of the patient groups are given in Table I. Of
the 31 cancer patients, 18 had lost little or no weight (weight-
stable), whereas 13 had lost more than 7.5% of their pre-
illness weight (weight-losing). Of the weight-stable cancer
patients: one had a gastro-oesophageal tumour; four had
gastric tumours; 12 had colorectal tumours and one patient
had a primary neoplasm of his gall bladder. The majority of
patients had localised disease, but 8 patients had Dukes C
lesions and one patient had hepatic metastases. In the
weight-losing group: five patients had gastric tumours; seven
colorectal tumours and one patient disseminated adenocar-
cinoma of unknown origin. There was only one Dukes B
lesion in this group; of the remainder, 6 patients had
Dukes C lesions and six patients hepatic metastases.
Dietary micronutrient assessment
Each patient was asked to complete a 7 day food record
prior to admission. This was sent to the patient along with a
comprehensive set of instructions on how to record food
intake. Each food portion was weighed and recorded. This
diet record was analysed and a computer programme based
on McCance and Widdowson's tables of food composition
(Paul & Southgate, 1978) used to compute the average daily
intakes of micronutrients.
Assays
Blood samples were taken in the morning without any
precautions with regard to diet. Blood for plasma vitamin C
Materials and methods
Forty-one consecutive patients admitted to the Surgical Unit
at Royal London Hospital were recruited to the study. These
comprised of thirty-one patients with histologically proven
gastrointestinal adenocarcinoma and ten weight-stable
patients of equal sex and age distribution, with benign
gastrointestinal disease who acted as controls. Benign gast-
rointestinal patients were chosen as controls to determine if
any observed changes are unique to cancer patients or reflect
changes to be found in any gastrointestinal pathology. The
Table I Clinical details of weight-stable and weight-losing cancer
patients and control patients
Cancer Cancer
Controls weight-stable weight-losing
Number 10 18 13
Sex (M/F) 5/5 11/7 8/5
Age (year) 64.3 64.9 68.0
mean (range) (35-79.7) (47.5-73.6) (47-79.5)
Height (cm) 167 2.8 167.2 1.8 165.8 1.2
mean (s.e.)
Weight (kg) at 68.7 ± 2.6 65.9 ± 2.3 60.3 ± 2.5
presentation
mean (s.e.)
% Weight loss - 1.97 ± 0.4 15.4 ± 0.9
mean (s.e.)
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was drawn into heparin; plasma was separated by centrifuga-
tion at 3000 rpm for 10 min. One ml of plasma was added to
2 ml of 5% trichloroacetic acid (TCA), kept at room
temperature for 30 min and then frozen. Frozen preparations
were kept at - 30°C for up to 3 months before vitamin C
assay. One gramme of red blood cells were added to 2 ml of
perchloric acid and frozen at - 30°C before thiamine
%assay.
(a) Vitamin C assay An aliquot of 0.5 ml of the super-
natant from TCA - precipitated plasma was estimated for
total vitamin C by the 2,4-dinitrophenylhydrazine technique
of Lowry as described by Roe (1954). The between-batch
coefficient of variation for the analytical technique was 10%
(rising to 17% at levels of vitamin C <0.3 mg dl-').
(b) Thiamine assay Red blood cell thiamine levels were
determined by the liquid chromatographic technique of
Kimura and Itokawa (1983). The between-batch coefficient of
variation for the analytical technique was 7.8%.
For several years before this study, the Department of
Chemical Pathology at the University of Leeds who per-
formed the assays had undertaken extensive studies of
vitamin levels in normal individuals, including those in insti-
tutions and the elderly at home. The reference values quoted
in Table II are derived from these studies (Newton et al.,
1985; C.J. Schorah 'personal communication').
(c) C-reactive protein assay C-reactive protein (CRP) was
estimated by single radial immunodiffusion using plates and
standards supplied by Behringwerke A.G, (Marburg, FRG).
The within batch coefficient of variation (CV) for the assay
was 2.9% (mean 26.8 mg 1-i (CRP), standard deviation
± 0.78, n = 10) while the between-batch CV measured using
a single serum in 20 different plates was 5.2% (mean
25 mg 1- I CRP, standard deviation ± 1.3).
(d) Prealbumin assay Prealbumin was measured using M-
PartigenTm prealbumin immunodiffusion plates (Hoechst,
UK). The coefficient of variation of the assay was 6.2%.
Results
Plasma vitamin C and red blood cell thiamine levels in each
of the patient groups is shown in Table II. Reference values
given are derived from extensive studies of vitamin levels in
normal individuals, including those in institutions and elderly
at home (Newton et al., 1985; Schorah 'personal communica-
tion').
The mean plasma vitamin C level of weight-losing cancer
patients (0.5 ± 0.09 mgdl-') was lower (P<0.05) compared
with weight-stable counterparts (0.8 ± 0.11 mg dl-'). Simi-
larly, the mean red blood cell thiamine levels ofweight-losing
cancer patients (107.4 ± 6.6 nmol Kg-' RBC) were lower
(P<0.02) compared with weight-stable counterparts
(134 ± 7.9 nmol Kg-' RBC). When all cancer patients irre-
spective of weight loss were compared to control patients,
there was no significant difference between plasma levels of
vitamin C (cancer: 0.7 ± 0.8 mg dl-'; control: 0.69 +
0.1 mg dl-') or red blood cell thiamine levels (cancer:
122.8 ± 5.8 nmol kg-' RBC; control: 107.3 ± 8.6 nmol kg-'
RBC).
There were similar daily intakes of protein and calories in
both weight-stable cancer patients and controls. The weight-
losing cancer patients were eating the same type of diet,
assessed by total daily energy intake, but consumed a smaller
quantity as shown in Table III. Thus, weight-losing cancer
patients had a lower (P = 0.05) intake of vitamin C
(34.1 ± 10.4mg/day, n = 10) compared with their weight-
stable counterparts (49.85 ± 6.6 mg/day, n = 17) and control
patients (51.1 ± 6.8 mg/day, n = 7). Similarly, weight-losing
cancer patients had a significantly lower (P<0.002) thiamine
intake (0.60 ± 0.06 mg/1,000 Kcals, n = 10), when compared
with both weight-stable cancer patients (0.64 ± 0.05 mg/
1,000 Kcals, n = 17) and controls (0.68 ± 0.06mg/1,000 Kcals,
n = 7) (Table III).
The correlations between average daily intake of vitamin C
(mg/day) and plasma vitamin C (mgdl-') in the control,
cancer weight-stable and cancer weight-losing groups were:
n=7, r,=0.64, NS; n= 17, r,=0.51, P=0.035; n= 10,
(e) Glucose tolerance test A standard oral glucose load of
75g in 250-350 ml of water was given to 26 patients: 11
cancer weight-stable; seven cancer weight-losing and six cont-
rol patients following an overnight fast. Blood samples were
taken before and at one and 2 h after the load (Leslie, 1985).
The plasma glucose results were entered into a microcom-
puter programme, from which integrated glucose level (viz.
the area under the glucose tolerance curve) was calculated.
The peak glucose concentration was also recorded.
Statistical analysis
Results are given as mean ± s.e.m. Statistical comparisons in
the pre-operative estimations were made by analysis of
variance (ANOVA). The follow up results were compared
with the pre-surgery values using a paired t-test.
Table II Plasma vitamin C and red blood cell thiamine levels in
weight-stable and weight-losing cancer patients and control
patients
Cancer Cancer
Controls weight-stable weight-losing
Vitamin C 0.69± 0.1 0.8 0.11 0.5±0.09a
(mgd-') n=10 n=18 n=13
Thiamine 107.3 ± 8.6 134 ± 7.9 107.4 ± 6.6b
(nmolkg-' RBC) n = 7 n = 18 n = 13
Values are means ± s.e.m. Statistical significance: ap <0.05 vs
weight-stable cancer patients; bp <0.02 vs weight-stable cancer
patients. Reference values: Vitamin C >0.35 mgdl-' (<60 years);
Vitamin C >0.20 mg dl-' (>60 years); Thiamine 120-222 nmol kg-'
RBC (all ages)
Table III Average daily intake of vitamin C and thiamine for 1
week prior to hospitalisation in weight-stable and weight-losing
patients with gastrointestinal adenocarcinoma and control patients
Cancer Cancer
Controls weight-stable weight-losing
n=7 n=17 n=10
Total energy (kcal) 2161 + 147 2198 ± 156 1234 + 158a
Total protein (g) 85.2 ± 6.2 80.8 ± 5 53.6 8.4b
Carbohydrate (g) 232 + 24 248 ± 22 134.4 ± 15c
Total fat (g) 100.5 6.6 95.5 5.8 53 ± 8.6d
Saturated fat (g) 34.1 2.7 31.4 2.5 21.4 3.5e
Unsaturated fat (g) 29.9 ± 2.6 28.3 ± 1.7 18.8 ± 3'
Fibre (g) 14.1±2 16.3±2.2 6.8 0.69
Vitamin C (mg) 51.1 ± 6.8 49.85 ± 6.6 34.1 ± 10.4h
Thiamine (B1) 0.68 + 0.06 0.64 + 0.05 0.60 ± 0.06
(mg/1,000 Kcals)
Values are means ± s.e.m. Statistical significance: ap <0.002 vs
weight-stable cancer patients (P <0.02 vs control patients);
bp <0.02 vs weight-stable cancer patients and control patients;
CP = 0.002 vs weight-stable cancer patients and control patients;
dp <0.002 vs weight-stable cancer patients and control patients;
'P = 0.05 vs control patients; fP <0.02 vs weight-stable cancer
patients (P = 0.05 vs control patients); 8P<0.02 vs weight-stable
cancer patients (P <0.002 vs control patients); hp = 0.05 vs
weight-stable cancer patients and control patients.
Vitamin C
Thiamine (B1)
LRNI
RNI
LRNI
RNI
(Dietary Reference Values for
HMSO, 1991).
10mg/day
40mg/day
0.4mg/1,000 Kcals (females)
0.6mg/1,000 Kcals (males)
0.8 mg/l,000 Kcals (females)
1.0mg/1,000 Kcals (males)
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r = -0.02, NS, respectively. The respective correlations
between average daily intake of thiamine and buffy coat
RBC thiamine levels were: n = 4, r, = 0.15, NS; n = 17,
r,=0.34, NS; n=10, r,=0.3, NS.
The mean plasma C-reactive protein level of weight-losing
cancer patients was higher (P<0.02) compared with weight-
stable counterparts and control patients. Similarly, the mean
prealbumin level of weight-losing cancer patients was lower
(P<0.05) compared with weight-stable counterparts and
control patients (Table IV). Considering the relationship
between plasma levels of prealbumin and C-reactive protein
in each of the patient groups, in control patients this was not
significant: n = 10, r, = 0.42. In cancer weight-stable patients
there was a statistically significant negative correlation:
n = 17, r, = -0.54, P = 0.03. Similarly, in cancer weight-
losing patients, there was a statistically significant negative
correlation: n = 12, r, = -0.6, P = 0.04.
As expected, there were negative correlations between
plasma vitamin C levels and plasma C-reactive protein con-
centration. In control patients: n = 10, r, = -0.31; cancer
weight-stable: n = 17, r, = -0.4; cancer weight-losing: n = 12,
rs = -0.2. These correlations failed to reach statistical
significance at the 5% level.
Considering the relationship between plasma vitamin C
levels and plasma prealbumin concentration, in control
patients there was a negative correlation which failed to
reach statistical significance: n = 10, r, = - 0.53. Positive cor-
relations were observed in both groups of cancer patients:
weight-stable: n = 17, r, = 0.75, P = 0.001 and weight-losing:
n=12, r,=0.15, NS.
Integrated glucose was higher in cancer weight-losing
patients (n = 7, 829.9 ± 55 mmol min) compared to their
weight-stable counterparts (n = 11, 722.3 + 62 mmol min).
Similarly, the peak glucose response in cancer weight-losing
patients (8.45 ± 0.6 mmol 1-') was higher compared to cancer
weight-stable patients (7.99 ± 0.7 mmol1`). However, these
differences failed to reach statistical significance.
Longitudinalfollow up vitamin C study
Twelve patients (11 male and one female) were followed up
after surgery on at least one occasion, and four underwent
sequential studies of vitamin C status and dietary intake over
a period of many months. The maximum period of follow up
being 18 months after surgery. The mean period of initial
follow up for all patients was 5.3 months with a range of 3 to
12 months.
Four patients had gastro-oesophageal tumours and eight
had colorectal tumours. All patients, except one, had under-
gone curative resection of their tumours as judged by clinical
examination, ultrasound scanning and/or computerised
tomography and 11 were in the weight-stable cancer group
preoperatively, with only the single female patient in the
weight-losing group. Patients were contacted in writing 2
weeks before their follow up appointments and the pre-
surgery method of assessing dietary intake was used over the
Table IV Acute phase reactants prealbumin and C-reactive protein
(CRP) in weight-stable and weight-losing cancer patients and control
patients
Cancer Cancer
Controls weight-stable weight-losing
CRP 15.9 ± 7.8 17.8 + 5.1 47.25 112.1a
(mgl') n=10 n=17 n=12
Prealbumin 250.3 ± 18.6 244.4 ± 22.1 173.9 + 21.5b
(mgl') n = 10 n = 17 n =12
Values are means ± s.e.m. Statistical significance: ap <0.02 vs
weight-stable cancer patients and control patients; bp <0.05 vs
weight-stable cancer patients and control patients.
Reference values: CRP <6 mg 1' (normal adults); (<20 mg 1'- no
significant effect of acute phase response on prealbumin or vitamin C
concentrations). Prealbumin <60 years: 210-460 mg 1- (males),
180-400mgl-' (females); >60 years: 200-420mgl-' (males),
160-400mg 1- (females).
7 days prior to their appointments. Average daily intakes of
all macro- and micronutrients were computed from a prog-
ramme based on McCance and Widdowson's tables of food
composition (Paul & Southgate, 1978).
It can be seen that overall, at 5.3 months after operation,
plasma vitamin C levels remained unchanged at
0.91 ± 0.1 mg dl-' compared to a pre-operative level of
0.98 ± 0.1 mg dl-'. Six patients were followed up for a
minimum of 9 months after surgery (mean 12.5 months,
range 9-18 months). In these patients, mean pre-operative
plasma vitamin C of 0.64 ± 0.1 mgdl-l increased to
0.78 ± 0.2 mg dl-' postoperatively. This difference was not
significant. There was a highly significant positive correlation
between plasma vitamin C levels and average daily intake of
vitamin C in 30 samples from the 12 patients on whom
follow up data were available: n = 30, rs=0.7, P<0.0001.
Plasma prealbumin and C-reactive protein results in the 12
patients on whom follow-up data were available, remained
relatively unchanged when pre-operative levels compared to
follow up values.
Red blood cell thiamine levels increased from a mean
pre-operative value of 139 ± 7.3 nmol Kg-' RBC to
153 ± 14.5 nmol Kg-' RBC in the 12 patients who were fol-
lowed up following surgery. In the six patients followed up
for a minimum of 9 months after surgery (mean 12.5 months,
range 9-18 months), mean pre-operative thiamine of
144 ± 8.4 nmol Kg-' RBC increased to 184 ± 28.5 nmol Kg-'
RBC following surgery. However, this difference was not
statistically significant.
Discussion
There has been heightened interest in the interaction of
vitamins with cancer and the potential use of the micronut-
rients as anticancer agents (McKeown-Eyssen et al., 1988).
Krasner and Dymock (1974) demonstrated a low vitamin
C status in heterogeneous cancer patients, including eight
with gastric neoplasia, eight with colorectal cancer and four
with pancreatic tumours, that was related to a reduced
dietary intake. However, other investigators (Anthony &
Schorah, 1982) have reported that whilst vitamin C levels
were diet dependent, this alone was not responsible for the
vitamin depletion. In this study, weight-losing patients with
gastrointestinal adenocarcinoma have been shown to have
lower levels of both plasma vitamin C and red blood cell
thiamine compared with weight-stable counterparts. In addi-
tion, weight-losing cancer patients have been shown to have
statistically significant lower daily intakes of both vitamin C
and thiamine when compared to weight-stable cancer patients
and controls. However, there were poor correlations between
dietary intake and vitamin status prior to surgery in all
patient groups, except the relationship for vitamin C in
cancer weight-stable patients.
Vitamin C is rapidly depleted in acute infections (Thomas
& Holt, 1978; Hume & Weyers, 1973). Since various acute
stress, including trauma and acute infections, are associated
with characteristic changes in several acute phase reactants,
the acute phase response has been measured in this study, by
measuring plasma prealbumin and C-reactive protein, regar-
ding possible concurrent contributory inflammatory process
to vitamin C status in cancer patients. A statistically
significant higher level of C-reactive protein and lower level
of prealbumin in the weight-losing cancer patients being
indicative of an 'acute state' contributing to the lower
vitamin status in these patients.
On the other hand, thiamine requirements are increased
during stress (Husami & Abumrad, 1986) and biochemical
deficiency of the vitamin can be demonstrated within a few
weeks of cessation of thiamine intake. Thus, lower vitamin C
and red blood cell thiamine status in weight-losing patients
with gastrointestinal adenocarcinoma prior to surgery were
associated with a lower dietary intake of these nutrients and
an acute phase response to their illness.
Since muscle loss has been shown previously to exert only1198 S.N. GEORGIANNOS et al.
a slight influence on glucose regulation (Moxley et al., 1983),
it is possible that the impaired glucose tolerance in cancer
weight-losing patients is a feature of thiamine deficiency.
The concentration of vitamin C in plasma and the buffy
layer has been shown to fall rapidly following major surgery
(Irvin et al., 1978). The most probable explanation for the
loss of vitamin C from plasma being an increased urinary
excretion during operation (Vallance, 1988). The previously
reported post-operative falls in buffy layer vitamin C have
been found to be the result of a major artefact in the
previously used methods for buffy cell vitamin C estimation,
caused by changes in the platelet to leucocyte ratio (Vallance,
1988). In this study, plasma vitamin C was unchanged at a
mean of 5 months following surgery for gastrointestinal
adenocarcinoma. This is to be expected in view of McGinn
and Hamilton's work (1976), in which, plasma vitamin C
concentrations are unaffected by surgery and post-operative
falls in buffy coat vitamin C returned to pre-operative values
after one week, unless patients received blood trans-
fusions.
Additionally, in the 12 patients with gastrointestinal cancer
who followed up sequentially after surgery, there was a
highly significant correlation between plasma vitamin C and
average daily intake of vitamin C. However, there was no
evidence of an acute phase response and therefore, dietary
intake of vitamin C appears to be the major factor in deter-
mining plasma vitamin C concentration following surgical
resection in these patients.
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